# A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

> **NCT06093230** · PHASE1 · COMPLETED · sponsor: **Shanghai Vinnerna Biosciences Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Subjects With Liver Function Injury
- Normal Liver Function Subject

## Interventions

- **DRUG:** Deuremidevir Hydrobromide Tablets

## Key facts

- **NCT ID:** NCT06093230
- **Lead sponsor:** Shanghai Vinnerna Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-28
- **Primary completion:** 2023-08-18
- **Final completion:** 2023-08-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093230, "A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06093230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*